The effect of various centrally active drugs on adenosine uptake by the central nervous system

https://doi.org/10.1016/0306-4492(82)90082-XGet rights and content

Abstract

1. Adenosine and its analogs depress the firing of neurons in various brain regions. The primary mode of action of adenosine in exerting this effect appears to be the depression of transmitter release from presynaptic nerve terminals. This is a result of reduced calcium mobilization.

2. Adenosine uptake inhibitors and deaminase inhibitors depress the firing of central neurons. Adenosine antagonists, caffeine and theophylline, excite central neurons, Adenosine is therefore likely to be released in sufficient quantities to exert an ongoing modulation of synaptic transmission in the intact brain.

3. A number of groups of centrally active drugs inhibit adenosine uptake by brain synaptosomal preparations. These include the benzodiazepines, phenothiazines, various other sedatives and hypnotics, tricyclic antidepressants, non-steroidal anti-inflammatory analgesics, some steriods, diphenlhydantoin, puromycin and toyocamycin.

4. It is proposed that many agents with anxiolytic, sedative, analgesic or anti-convulsant actions may achieve their effects by inhibiting adenosine uptake and thus potentiating extracellular adenosine levels.

5. Morphine also elevates extracellular adenosine levels but achieves this by enhancing adenosine release.

References (63)

  • G.C. Palmer

    Interactions of anti-epileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum

    Exp. Neurol.

    (1979)
  • J.W. Phillis et al.

    The effect of morphine on purine and acetylcholine release from rat cerebral cortex: evidence for a purienergic component in morphine's action

    Pharmac. Biochem. Behav.

    (1980)
  • J.W. Phillis et al.

    Adenosine as a putative transmitter in the cerebral cortex: Studies with potentiators and antagonists

    Life Sci.

    (1975)
  • J.W. Phillis et al.

    The role of adenosine and its nucleotides in central synaptic transmission

    Prog. Neurobiol.

    (1981)
  • P. Polc et al.

    Caffeine antagonizes several central effects of diazepam

    Life Sci.

    (1981)
  • J.A. Ribeiro et al.

    Adenosine and adenosine triphosphate decrease 45Ca uptake by synaptosomes stimulated by potassium

    Biochem. Pharmac.

    (1979)
  • A. Sattin et al.

    Biochemical and electropharmaceutical studies with tricyclic antidepressants in rat and guinea-pig cerebral cortex

    Life Sci.

    (1978)
  • M.A. Shamsi et al.

    Correlation of chemical structure of phenothiazines with their coronary dilator and antiarrhythmic activities

    Jap. J. Pharmac.

    (1971)
  • P.H. Wu et al.

    Do benzodiazepines bind at adenosine uptake sites in CNS?

    Life Sci.

    (1981)
  • R.J. Baldessarini

    Drugs and the treatment of psychiatric disorders

  • B. Beer et al.

    Cyclic adenosine monophosphate phosphodiesterase in brain: effect in anxiety

    Science, N.Y.

    (1972)
  • A.S. Bender et al.

    The characterization of 3H-adenosine uptake into rat cerebral cortical synaptosomes

    J. Neurochem.

    (1980)
  • A.S. Bender et al.

    The rapid uptake and release of [3H] adenosine by rat cerebral cortical synaptosomes

    J. Neurochem.

    (1981)
  • S. Brailowsky et al.

    Morphine-theophylline interaction: antagonism or facilitation?

    Br. J. Pharmac.

    (1981)
  • D.D. Branisteanu et al.

    Adenosine effects upon transmitter release parameters in the Mg2+-paralyzed neuromuscular junction of frog

    Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.

    (1979)
  • P.V. Buday et al.

    A pharmacologic study of some nucleosides and nucleotides

    J. Pharm. Pharmac.

    (1961)
  • K. Budd

    Psychotropic drugs in the treatment of chronic pain

    Anaesthesia

    (1978)
  • J. Charpentier

    Nouvelle recherche sur le mécanisme d'action de certains analgesiques centraux (acideacetylsalicylique, impramine, iminostilbène)

    Psychopharmacology

    (1966)
  • A.S. Clanachan et al.

    Coronary vasodilator and benzodiazepine inhibition of site-specific binding of nitrobenzylthionosine, an inhibitor or nucleoside transport, to human erythrocytes

    Br. J. Pharmac.

    (1981)
  • L. Cook et al.

    Behavioral analysis of the effects and mechanisms of action of benzodiazepines

    Adv. Biochem. Psychopharmac.

    (1975)
  • S.H. Curry et al.

    Chlorpromazine plasma levels levels and effects

    Archs gen. Psychiat.

    (1970)
  • Cited by (136)

    • Antidepressants as Analgesics

      2013, Practical Management of Pain: Fifth Edition
    • Antidepressants as Analgesics

      2013, Practical Management of Pain: Fifth Edition
    • Comorbidity of insomnia and depression

      2010, Sleep Medicine Reviews
      Citation Excerpt :

      Interestingly, this A2A polymorphism has been associated with susceptibility to panic disorder134,135 and with the anxiogenic response to caffeine in healthy volunteers.136 In major depression, some evidences suggest a deficit in adenosinergic transmission,137,138 and studies indicate that adenosine could be implicated in mood regulation139–143 and in the antidepressant effects of sleep deprivation or of electroconvulsive therapy.144 REM sleep disinhibition observed in major depression but not in insomnia may directly relate to the monoamine hypothesis of depression that postulates a deficiency of noradrenaline (NA) and serotonin (5-HT) neurotransmission, because there are strong evidences that REM sleep generating neurons are under the opposite influence of inhibitory NA and 5-HT input and of excitatory cholinergic input.145,146

    • Differential effects of caffeine on the antidepressant-like effect of amitriptyline in female rat subpopulations with low and high immobility in the forced swimming test

      2008, Physiology and Behavior
      Citation Excerpt :

      Moreover, the fact that caffeine counteracted the anti-immobility effect of amitriptyline in HI-rats but induced an antidepressant-like effect when applied alone suggests that endogenous adenosine can produce opposite behavioral effects depending on whether the 5-HT/noradrenergic transmission is enhanced or not. Previous studies have shown that TCA drugs inhibit adenosine uptake in brain cortical synaptosomes [52], explaining the observation that iontophoretically applied TCAs depress the firing rate of cortical neurons in vivo, and enhance the inhibitory actions of adenosine but not of an uptake-resistant analog [5]. The inhibitory effect of locally applied TCAs can be antagonized by systemic caffeine, suggesting that the increase of extracellular adenosine induced by these antidepressants is large enough to induce a significant activation of neuronal adenosine receptors [5].

    View all citing articles on Scopus

    Present address: Department of Physiology, School of Medicine, Wayne State University, Detroit, MI 48201, U.S.A.

    View full text